A detailed history of Srs Capital Advisors, Inc. transactions in Atrion Corp stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 6 shares of ATRI stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Holding current value
$0
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$381.09 - $495.99 $2,286 - $2,975
6 New
6 $2,000
Q4 2022

Feb 24, 2023

BUY
$551.1 - $688.5 $551 - $688
1 Added 0.71%
141 $78,000
Q2 2022

Aug 22, 2022

BUY
$605.0 - $763.25 $1,815 - $2,289
3 Added 2.19%
140 $88,000
Q3 2021

Nov 05, 2021

BUY
$594.24 - $758.0 $594 - $758
1 Added 0.74%
137 $95,000
Q2 2021

Aug 02, 2021

BUY
$582.88 - $670.99 $19,817 - $22,813
34 Added 33.33%
136 $85,000
Q4 2020

Feb 03, 2021

BUY
$576.6 - $672.2 $33,442 - $38,987
58 Added 131.82%
102 $66,000
Q3 2020

Nov 12, 2020

BUY
$620.1 - $689.89 $27,284 - $30,355
44 New
44 $28,000

Others Institutions Holding ATRI

About ATRION CORP


  • Ticker ATRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 1,785,990
  • Description
  • Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...
More about ATRI
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.